Tylenol Autism Lawsuit Reinstated: Appeals Court Revives Claims Over Acetaminophen Safety During Pregnancy
Could Tylenol Use During Pregnancy Increase Autism Risk? Appeals Court Allows Lawsuit to Move Forward
A major legal development has brought renewed attention to one of the most debated topics in maternal health. A federal appeals court has revived lawsuits claiming that the makers of Tylenol failed to warn consumers about potential risks associated with taking acetaminophen during pregnancy.
The ruling does not determine whether Tylenol causes autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD). Instead, it allows expert testimony to be reconsidered, giving plaintiffs another opportunity to present their scientific evidence in court.
As research on prenatal acetaminophen exposure continues to evolve, this decision has sparked fresh discussions among healthcare professionals, researchers, and expecting parents.
Appeals Court Reverses Earlier Decision
On July 13, 2026, the U.S. Court of Appeals for the Second Circuit ruled that a lower court improperly excluded testimony from several scientific experts involved in the case.
The panel concluded that the district judge exceeded her role by dismissing expert opinions without applying consistent legal standards. According to the appeals court, judges should evaluate whether expert testimony is reliable and relevant, rather than deciding between competing scientific interpretations.
The ruling means the lawsuits will continue instead of being dismissed at this stage.
What Are the Lawsuits About?
The lawsuits were filed by families who allege that taking acetaminophen, the active ingredient in Tylenol, during pregnancy contributed to their children's diagnosis of autism or ADHD.
The plaintiffs argue that the manufacturer should have warned consumers about possible neurodevelopmental risks linked to prenatal exposure.
It is important to note that these claims remain allegations and have not been proven in court.
Why Expert Testimony Matters
Scientific experts play a central role in complex product liability cases involving health issues.
The appeals court specifically addressed testimony from several experts, including:
- Dr. Andrea Baccarelli
- Dr. Eric Hollander
- Brandon Pearson
- Dr. Roberta Ness
The judges stated that disagreements among qualified scientists do not automatically make an expert's opinion unreliable.
One key issue involved accusations that experts selectively relied on studies supporting their conclusions while ignoring conflicting research.
The appeals court explained that choosing one study over another is not necessarily "cherry-picking" if the expert provides a reasonable scientific explanation for that preference.
According to the judges, legitimate scientific debate exists regarding the role of genetics and environmental factors in autism and ADHD.
Does This Mean Tylenol Causes Autism?
No.
The appeals court made it clear that its decision does not establish that acetaminophen causes autism or ADHD.
Instead, the ruling focuses on whether the expert witnesses should be allowed to testify before a jury.
Questions about causation remain unresolved and continue to be the subject of ongoing scientific research.
What Does Current Research Say?
Research examining acetaminophen use during pregnancy has produced mixed findings.
Some observational studies have reported an association between prenatal acetaminophen exposure and a higher risk of neurodevelopmental disorders, including autism and ADHD.
Other studies have found little or no significant association after accounting for genetic, environmental, and medical factors.
Because these studies often rely on observational data rather than randomized clinical trials, researchers cannot definitively conclude that acetaminophen directly causes these conditions.
Many scientists continue to investigate the issue while emphasizing that additional high-quality research is needed.
Manufacturer Responds
Kenvue, the current manufacturer of Tylenol, responded by stating that the appeals court ruling is procedural and does not establish a medical link between acetaminophen and developmental disorders.
The company maintains that extensive scientific evidence supports the safety of acetaminophen when used as directed.
Kenvue also stated that it plans to continue defending the lawsuits and challenge the reliability of the plaintiffs' expert testimony during future proceedings.
Internal Company Documents Draw Attention
The legal battle has also highlighted internal communications from Johnson & Johnson, which previously manufactured Tylenol before Kenvue became the brand's owner.
One publicly disclosed 2018 email reportedly stated that the growing body of evidence connecting prenatal acetaminophen exposure with neurodevelopmental disorders was beginning to appear increasingly significant.
While internal discussions do not establish scientific proof, such documents have become part of the broader legal proceedings.
Updated Scientific Reviews
Recent scientific reviews have continued examining available evidence.
One review published in 2025, coauthored by Harvard public health researcher Dr. Andrea Baccarelli, concluded that existing research suggests prenatal acetaminophen exposure may be associated with an increased risk of autism and other neurodevelopmental conditions.
However, other researchers continue to question these conclusions and point to studies showing no meaningful association.
This ongoing disagreement illustrates why the issue remains scientifically and legally controversial.
Guidance for Pregnant Women
Health experts generally advise pregnant women not to stop taking any medication without consulting their healthcare provider.
Acetaminophen has long been considered one of the preferred pain relievers during pregnancy because many alternative medications may carry greater known risks.
Doctors typically recommend:
- Using medications only when medically necessary.
- Taking the lowest effective dose.
- Limiting use to the shortest appropriate duration.
- Discussing any concerns with an obstetrician or healthcare professional.
Every pregnancy is different, and treatment decisions should always be individualized.
What Happens Next?
Following the appeals court decision, the lawsuits will return to the lower court for additional proceedings.
Expert witnesses may now have another opportunity to present their scientific analyses before a jury.
The litigation could influence future legal actions involving acetaminophen, but it does not change current medical guidelines or establish legal liability.
The outcome of these cases may also shape how courts evaluate scientific evidence in future product liability disputes.
Final Thoughts
The Second Circuit's ruling represents an important procedural development in the ongoing Tylenol autism litigation. While the decision revives lawsuits that had previously been dismissed, it does not determine whether acetaminophen causes autism or ADHD.
Scientific research on prenatal acetaminophen exposure remains active, with experts continuing to debate the strength and interpretation of available evidence.
For consumers, the key takeaway is that this case concerns the admissibility of expert testimony rather than a final scientific or legal conclusion. Individuals with questions about medication use during pregnancy should seek advice from qualified healthcare professionals rather than relying solely on ongoing litigation.
Disclaimer
This article is intended for informational and educational purposes only and should not be considered medical or legal advice. The legal claims discussed remain ongoing, and no court has determined that acetaminophen or Tylenol causes autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD). Always consult a qualified healthcare provider before making decisions about medications during pregnancy.
Source
The Epoch Times, published on July 13, 2026, along with statements referenced from the U.S. Court of Appeals for the Second Circuit and the parties involved in the litigation.